 | Up a level |
2017
Goetze, T. O., Al-Batran, S-E., Zander, T., Reichart, A., Lindig, U., Kleiss, M., Mueller, L., Bolling, C., Seufferlein, T., Reichardt, P., Kullmann, F., Eschenburg, H., Schmittel, A., Egger, M., Block, A., Pauligk, C. and Schmalenberg, H. (2017). A multicentre, phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the oesophagogastric junction and stomach (CABAGAST). Ann. Oncol., 28. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041
Goetze, T. O., Schmalenberg, H., Pauligk, C., Zander, T., Reichart, A., Lindig, U., Kleiss, M., Mueller, L., Bolling, C., Seufferlein, T., Reichardt, P., Kullmann, F., Eschenburg, H., Schmittel, A., Egger, M., Block, A. and Al-Batran, S. -E. (2017). A multicentre, phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the oesophagogastric junction and stomach (CABAGAST). Oncol. Res. Treat., 40. S. 209 - 210. BASEL: KARGER. ISSN 2296-5262
2012
Gawenda, M., Block, A., Majd, P. M. and Brunkwall, J. (2012). Is There a Role for Risk-Scoring Methods in Ruptured Abdominal Aortic Aneurysm (rAAA)? Zent.bl. Chir., 137 (5). S. 453 - 460. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-9592